SAN DIEGO--(BUSINESS WIRE)--Youngevity International, Inc. (OTCQX: YGYI) (www.YGYI.com), a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announces the launch of an advanced anti-aging supplement, Imortalium™ into our global direct sales channel.
Imortalium™ combines the most effective anti-aging nutrients in a cutting-edge, bi-layered and extended release tablet that nutritionally helps promote cellular longevity and telomere health to help slow the natural aging process. Imortalium™ contains synergizing antioxidant enzymes and essential nutrients that offer among the greatest telomere support.
In order to further advance the anti-aging qualities of Imortalium™, it has been packaged in a unique, technologically advanced Miron violet glass bottle. The Miron violet glass works as a filter that blocks the complete spectrum of visible light with the exception of the violet wave length to protect the quality of the nutrients in each tablet.
William Andreoli, President of Youngevity International said, “The global anti-aging product market is growing and expected to reach over $290 billion by 2015, which is fuelled by the aging population seeking anti-aging support in the form of nutritional supplementation. The importance of telomeres to health and ageing continues to grow. The discovery of telomeres and how they protect the ends of chromosomes against degradation had a major impact within the scientific community and a team of scientists were awarded a Noble Prize in Physiology of Medicine in 2009. Youngevity is dedicated to delivering solutions to help health-conscious people Live Younger, Longer and we believe Imortalium is a solution for healthy aging.”
“We received a very enthusiastic response from our global distributor and customer base during the launch of our new breakthrough anti-aging supplement, Imortalium, on December 31st,” said Steve Wallach, Youngevity’s Chief Executive Officer. “We are very excited about the tremendous potential benefits and results of Imortalium to combat aging and believe we have a great opportunity to make a major impact in the growing multi-billion dollar anti-aging global product market. We filed a trademark for the name Imortalium through the U.S. Patent and Trademark Office (USPTO) in January 2013 and we anticipate the registration of the trademark early this year.”
“Our New Year’s Eve conference call was a huge success and a great way to start the year for our growing Company,” said Dave Briskie, Chief Financial Officer of Youngevity International. “We made other major announcements during the call, which included the introduction of our Youngevity 90 for Life mobile app to bring our sales platform into the mobile world of smartphones and tablets. We also introduced our multi-vitamin/mineral complex on-the-go Beyond Tangy Tangerine 2.0 Stick Packs and Beyond Hot Chocolate made from organic cacao beans. We will continue to accelerate our expansion into various international markets and expect this will be a major growth driver for the next several years.”
For additional information regarding Youngevity’s products, visit: www.YGYI.com
About Youngevity International Inc.
Youngevity International Inc., (OTCQX: YGYI) (www.YGYI.com ) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a "network of networks." The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. The Company was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011. The company was formerly known as AL International, Inc. and changed its name to Youngevity International Inc. in July 2013.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. The forward-looking statements contained in this press release include statements regarding the Company’s expected future growth and the potential benefit of Imortalium as a solution for healthy aging. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.